| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/28/1997 | WO1997030705A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997019953A3 New lh-rh antagonists with improved effectiveness |
| 08/28/1997 | CA2247481A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | CA2247130A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | CA2247025A1 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | CA2246721A1 Benzothiophenes, formulations containing same, and methods |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2241142A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| 08/27/1997 | EP0791591A1 Benzothiophenes, formulations containing same, and methods |
| 08/27/1997 | EP0791590A1 Benzothiophenes, and formulations and methods using same |
| 08/27/1997 | EP0791588A1 Process for the preparation of derivatives of amino-ascorbic acid |
| 08/27/1997 | EP0791587A1 Process for the preparation of derivatives of amino-ascorbic acid |
| 08/27/1997 | EP0791580A2 Novel derivatives of 3-bromo and 3,3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
| 08/27/1997 | EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0791050A1 Vectors for tissue-specific replication |
| 08/27/1997 | EP0790997A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 08/27/1997 | EP0790986A1 Aniline derivatives |
| 08/27/1997 | EP0790974A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/27/1997 | EP0790835A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/27/1997 | EP0790769A1 Eleutherobin and analogs thereof |
| 08/27/1997 | EP0683788B1 3'-aziridino-anthracycline derivatives |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0592438B1 Indole derivatives |
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1157818A 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
| 08/27/1997 | CN1157719A Percutaneous applied medicine contained gestodene |
| 08/27/1997 | CN1157716A Metastasis suppressory agents |
| 08/26/1997 | US5661179 Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661156 Administering to inhibit the growth of pathogenic fungi, to induce immunosuppression, and to treat carcinogenic tumors in humans and animals |
| 08/26/1997 | US5661155 Treatment of cancer with pharmaceutically active benzoquinazoline compounds |
| 08/26/1997 | US5661140 Treating psoriasis |
| 08/26/1997 | US5661136 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
| 08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | US5660827 Antibodies that bind to endoglin |
| 08/26/1997 | CA1339389C Purified protein a compositions and methods for their preparation |
| 08/26/1997 | CA1339368C Optically active compounds |
| 08/26/1997 | CA1339367C Purified hematoporphyrin trimers useful in photodynamic therapy |
| 08/26/1997 | CA1339356C Human platelet-derived growth factor receptor |
| 08/22/1997 | CA2198176A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/21/1997 | WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 08/21/1997 | WO1997030085A1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/21/1997 | WO1997030079A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | WO1997030061A1 Methods of synthesizing gm2 |
| 08/21/1997 | WO1997030053A1 Farnesyl transferase inhibitors |
| 08/21/1997 | WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | WO1997030044A1 Quinazoline compounds |
| 08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
| 08/21/1997 | WO1997030034A1 Quinazoline derivatives as antitumor agents |
| 08/21/1997 | WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | WO1997029779A2 Egf-genistein conjugates for the treatment of cancer |
| 08/21/1997 | WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | WO1997029769A1 Vaccine for b-cell malignancies |
| 08/21/1997 | WO1997029759A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 08/21/1997 | CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | CA2245863A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| 08/21/1997 | CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | CA2218378A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | CA2217708A1 Methods of synthesizing gm2 |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0790309A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790308A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790255A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790245A1 Substituted Thiophenylalkenylcarbonylguanidide, method for their preparation, their use as medicinal or diagnostic agent as well as medicament containing them |
| 08/20/1997 | EP0789783A1 Antigen binding peptides (abtides) from peptide libraries |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789766A1 Chimeric papillomavirus-like particles |
| 08/20/1997 | EP0789716A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789711A1 IDENTIFICATION OF THE p21?WAF1 -PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF |
| 08/20/1997 | EP0789706A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789591A1 Methods for identifying individuals suffering from a cellular abnormality |
| 08/20/1997 | EP0789588A1 Method for making a medicament for treating secondary immunodeficiency |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789568A1 Antineoplastic cocoa extracts, methods for making, using |
| 08/20/1997 | EP0789564A1 Polynucleotide compositions |
| 08/20/1997 | EP0662954B1 Novel vitamin d analogues |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | CN1157619A Pyrimido £5-4-d| pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 08/20/1997 | CN1157618A Novel substituted purinyl derivatives with immunomodulating activity |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157571A Use of IL-4 for potentiation of chemotherapeutic agents |